Inventor · disambiguated record
Jinwang Xu
Also filed as: XU JINWANG
33 granted patents·7 pending applications·361 citations·filing 2003–2023
97Inventor score
Top patents by PatentIndex Score
40 records- 0198US9376448B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2013·Granted Jun 28, 2016·46 cites·10 claims
- 0297US9925188B2DNA-PK inhibitors and uses thereofVERTEX PHARMA·Filed 2016·Granted Mar 27, 2018·24 cites·18 claims
- 0396US9592232B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted Mar 14, 2017·24 cites·13 claims
- 0496US8344153B2Inhibitors of phosphatidylinositol 3-kinaseVERTEX PHARMA·Filed 2010·Granted Jan 1, 2013·47 cites·16 claims
- 0596US7872031B2c-MET protein kinase inhibitorsVERTEX PHARMA·Filed 2007·Granted Jan 18, 2011·64 cites·12 claims
- 0695US9359380B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted Jun 7, 2016·19 cites·25 claims
- 0795US9340557B2Substituted quinoxaline DNA-PK inhibitorsVERTEX PHARMA·Filed 2014·Granted May 17, 2016·19 cites·26 claims
- 0895US9296701B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2013·Granted Mar 29, 2016·21 cites·17 claims
- 0994US9878993B2DNA-PK inhibitors for treatment of cancerVERTEX PHARMA·Filed 2016·Granted Jan 30, 2018·10 cites·7 claims
- 1093US10786512B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Sep 29, 2020·3 cites·8 claims
- 1192US10973830B2Substituted quinoxaline DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Apr 13, 2021·3 cites·23 claims
- 1292US10076521B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2017·Granted Sep 18, 2018·7 cites·21 claims
- 1391US11884672B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2020·Granted Jan 30, 2024·4 cites·11 claims
- 1491US10501439B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Dec 10, 2019·5 cites·18 claims
- 1591US10442791B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Oct 15, 2019·5 cites·13 claims
- 1691US10391095B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2018·Granted Aug 27, 2019·5 cites·9 claims
- 1790US9987284B2Substituted benzooxadiazole DNA-PK inhibitorsVERTEX PHARMA·Filed 2016·Granted Jun 5, 2018·5 cites·23 claims
- 1889US12331057B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·1 cites·11 claims
- 1989US10258627B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·4 cites·19 claims
- 2088US7279469B2Diaminotriazoles useful as inhibitors of protein kinasesVERTEX PHARMA·Filed 2003·Granted Oct 9, 2007·36 cites·15 claims
- 2186US12251387B2Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitorsVERTEX PHARMA·Filed 2023·Granted Mar 18, 2025·0 cites·20 claims
- 2281US8232406B2c-MET protein kinase inhibitorsLAUFFER DAVID J·Filed 2010·Granted Jul 31, 2012·6 cites·11 claims
- 2379US11623924B2Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2019·Granted Apr 11, 2023·3 cites·15 claims
- 2477US2021236505A1Substituted quinoxaline dna-pk inhibitorsVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2576US11813267B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2020·Granted Nov 14, 2023·0 cites·19 claims
- 2676US11021465B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Jun 1, 2021·0 cites·22 claims
- 2775US11008305B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted May 18, 2021·0 cites·20 claims
- 2869US2018311254A1Dna-pk inhibitorsVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 2968US2023265080A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 3064US2016354381A1Dna-pk inhibitorsObligated Assignee·Filed 2016·Application pending·0 cites
- 3155US7902239B2Diaminotriazoles useful as inhibitors of protein kinasesVERTEX PHARMA·Filed 2007·Granted Mar 8, 2011·0 cites·6 claims
- 3253US2023339915A1Modulators of alpha-1 antitrypsinVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3352US2023159580A1Pyrrolo[2,3-f]indazole and 2,4,5,10-tetrazatricyclo[7.3.0.03,7]dodeca-1,3(7),5,8,11-pentaene derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3452US2023159521A11h-pyrazolo[4,3-g]isoquinoline and 1h-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3550US7973162B2Modulators of muscarinic receptorsVERTEX PHARMA·Filed 2008·Granted Jul 5, 2011·0 cites·25 claims
- 3648US7786107B2Modulators of muscarinic receptorsVERTEX PHARMA·Filed 2007·Granted Aug 31, 2010·0 cites·39 claims
- 3747US7858790B2Modulators of muscarinic receptorsVERTEX PHARMA·Filed 2007·Granted Dec 28, 2010·0 cites·29 claims
- 3846US12005127B2DNA-PK inhibitorsVERTEX PHARMA·Filed 2019·Granted Jun 11, 2024·0 cites·48 claims
- 3942US8304423B2Modulators of muscarinic receptorsDAVIES ROBERT J·Filed 2011·Granted Nov 6, 2012·0 cites·20 claims
- 4038US8524906B2Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinaseARONOV ALEX·Filed 2011·Granted Sep 3, 2013·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Jinwang Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →